Parasite-microbe-host interactions and cancer risk
Nolwenn M. Dheilly,Paul W. Ewald,Paul J. Brindley,Raina N. Fichorova,Frédéric Thomas
DOI: https://doi.org/10.1371/journal.ppat.1007912
IF: 7.464
2019-08-15
PLoS Pathogens
Abstract:Characterizing the factors that disrupt the cellular barriers to cancer (e.g., cell-cycle arrest, apoptosis, repression of telomerase, cell adhesion, and asymmetric cell division) and are essential to oncogenesis is necessary to identify targets for therapeutic interventions [<a class="ref-tip" href="#ppat.1007912.ref001">1</a>]. Exacerbating causes can contribute to cancer by compromising host restraints on cancer rather than breaking barriers; examples of such exacerbating causes are factors that drive angiogenesis, or increased proliferation during pro-inflammatory responses [<a class="ref-tip" href="#ppat.1007912.ref001">1</a>]. All viruses that are recognized by the International Agency for Research on Cancer (IARC) as Group 1 carcinogens, namely human papillomaviruses (HPV), Hepatitis B and C viruses (HBV and HCV), Human Herpes Virus type 8 (HHV-8), and Human T-cell lymphotropic virus type 1 (HTLV-1) [<a class="ref-tip" href="#ppat.1007912.ref002">2</a>], break barriers to cancer and therefore generate essential causes of their associated cancers [<a class="ref-tip" href="#ppat.1007912.ref001">1</a>]. These may be the result of natural selection. For example, from an evolutionary point of view, it is probably advantageous to a virus that its host cell resists cell death, evades the immune system, and proliferates. Other intracellular organisms (bacteria and unicellular eukaryotes) could similarly benefit from altering the cellular mechanisms that prevent oncogenesis. Indeed, the ability of intracellular bacteria and protozoan parasites to block apoptosis is now broadly recognized [<a class="ref-tip" href="#ppat.1007912.ref003">3</a>,<a class="ref-tip" href="#ppat.1007912.ref004">4</a>]. Increasing evidence implicates bacteria (certain strains of <em>Escherichia coli</em>, <em>Fusobacterium nucleatum</em>, <em>Salmonella</em> Typhi, <em>Chlamydia trachomatis</em>, and a range of <em>Mycoplasma</em>) and protists (<em>Cryptosporidum parvum</em>, <em>Trichomonas vaginalis</em>, <em>Trypanosoma cruzi</em>, <em>Toxoplasma gondii)</em> in cancer development [<a class="ref-tip" href="#ppat.1007912.ref002">2</a>, <a class="ref-tip" href="#ppat.1007912.ref005">5</a>–<a class="ref-tip" href="#ppat.1007912.ref026">26</a>].For extracellular parasites, and in particular helminths, the evolutionary path that could lead them to break the cellular barriers to cancer is more difficult. At present, three multicellular parasites, the trematodes <em>Schistosoma haematobium</em>, <em>Opisthorchis viverrini</em>, and <em>Clonorchis sinensis</em> are recognized as Group 1 carcinogens by IARC, contributing 0.4% to human cancer [<a class="ref-tip" href="#ppat.1007912.ref002">2</a>]. However, increased risk of cancer is associated with increasing numbers of other parasites, e.g., species of <em>Echinococcus</em>, <em>Strongyloides</em>, <em>Fasciola</em>, <em>Heterakis</em>, <em>Platynosomum</em>, and <em>Trichuris</em> [<a class="ref-tip" href="#ppat.1007912.ref027">27</a>] and is likely broadly underestimated due to the asymptomatic/subclinical nature of some of these infections, wide occurrence among healthcare underserved communities, and long latency between initial infection or exposure and clinical manifestation of cancer. The latest advances in microbiology suggest a new paradigm—multi-microbial factors could explain why and how some parasites breach host barriers to cancer. Herein, we review the literature indicating that microbes can contribute in an essential sense to oncogenesis through their interaction with the host and with parasites.
microbiology,virology,parasitology